CDC updates COVID care guidance for independent and assisted living … Eisai to seek full approval of Alzheimer’s drug lecanemab … Roche halts failed clinical trials of Alzheimer’s drug gantenerumab … FDA puts only remaining COVID antibody treatment on pause … COVID vaccine’s effectiveness diminishes with age, researchers find
Clinical briefs for Friday, Dec. 2
December 2, 2022